MCI launches mandatory foundation course for all MBBS students
The Medical Council of India (MCI) has rolled out a mandatory one-month foundation course for all the MBBS students across the country, as reported in Times of India. As part of the Professionalism and Ethics module, students will also learn about disability rights,... read more
UN health agency spotlights stalled effort to close health divide across Europe
Progress on equal access to a healthy life for all, is at a standstill across Europe, a new report by the World Health Organization (WHO) revealed on Tuesday, despite there being a clear path to close gaps in national care.... read more
Nutrition International conducts India Iodine Survey 2018-19
Nutrition International, a global nutrition organization, conducted a country-wide study – India Iodine Survey 2018-19 - to estimate the iodine status of the population and assess the extent to which Indian households have access to adequately iodised salt.... read more
Erectile dysfunction may predict strokes and heart attacks
Erectile dysfunction (ED) may predict your risk for a future stroke or heart attack, suggests a meta-analysis of studies on more than 150,000 men published in the Journal of Sexual Medicine. Compared to men without symptoms of impotence,... read more
New Strep A Strain Linked to Scarlet Fever and Sepsis
A new strain of group A streptococcus bacteria called M1UK linked to scarlet fever and sepsis has been identified in England and Wales.
The discovery was made by researchers led by Imperial College London who report their findings in the Lancet Infectious Diseases.... read more
ORION-11: 50% Reduction in LDL With Twice-Yearly Injection
Phase 3 trial results show a 50% reduction in low-density lipoprotein cholesterol (LDL) levels with a twice-yearly subcutaneous injection of the novel RNA agent inclisiran.
Results of the first of three phase 3 trials, ORION-11, presented at the European Society of Cardiology (ESC) Congress 2019,... read more
FDA approves an easy-to-use glucagon rescue pen for severe hypoglycemia in diabetes
The US Food and Drug Administration (FDA) has approved a prefilled glucagon rescue pen (Gvoke HypoPen, Xeris Pharmaceuticals) for the treatment of severe hypoglycemia in adult and pediatric patients aged 2 years or older who have diabetes.... read more